瑞典LifeAssays
LifeAssays® AB 由Dario Kriz教授于2000年创立, Dario Kriz教授早期在隆德大学工作时即专注发展磁性奈米微粒在生物技术及医学研究范畴的运用。经多年领先的研究成果和专利的奈米微粒检测血液成份及生物标志技术成为今天LifeAssays® 强而有力核心技术。

LifeAssays® 是一家快速成长兼具研发及制造能力的体外诊断试剂仪器公司，在瑞典斯德哥尔摩Nordic Growth Market stock exchange 股票市场上市。目前除了在人医市场有CRP及High Sensitivy-CRP两种产品外，在宠物市场有犬CRP的专用仪器及试剂已上市。

LifeAssays® is a Swedish diagnostic company focused on providing accurate and affordable point-of-care diagnostic testing for veterinarians, community health centres and primary physicians based on our unique, patented point-of-care technology platform. LifeAssays® AB was founded in 2000.

The technology was developed at Lund University, Sweden, and is based on small, nano-size magnetic particles and their subsequent application in biotechnological and medical research. The unique, patented point-of-care technology is composed of nano-size magnetic particles and a detector system for the identification of biological markers utilizing the technology. This point-of- care platform is the foundation of the diagnostic company LifeAssays®.

Today LifeAssays® is a growing diagnostic company with in-house development, manufacturing and market & sales. The company has been listed on the Nordic Growth Market stock exchange in Stockholm, Sweden since 2003.

LifeAssays will develop complete solutions involving a wide range of point-of-care tests used on the unique platform to offer the veterinary and human diagnostic market state-of-the-art products.